Non-interventional Local Study to Describe the Safety, Tolerability and Efficacy of Bevacizumab in Combination With Standard Chemotherapy Regimens as First Line in Patients With Metastatic Cancer of the Colon or the Rectum
Phase of Trial: Phase IV
Latest Information Update: 08 Jul 2016
At a glance
- Drugs Bevacizumab (Primary) ; Antineoplastics
- Indications Colon cancer; Colorectal cancer; Rectal cancer
- Focus Adverse reactions
- Sponsors Roche
- 01 Jul 2016 Status changed from active, no longer recruiting to completed.
- 11 May 2015 Status changed from recruiting to active, no longer recruiting, according to to ClinicalTrials.gov record.
- 01 Apr 2015 According to the ClinicalTrials.gov record, status changed from active, no longer recruiting to recruiting.